What is the recommended starting dose and titration schedule of metoprolol (tartrate) for controlling hypertension and anxiety, and what monitoring parameters and side‑effect thresholds should be used?

Metoprolol for Hypertension and Anxiety

Direct Answer

For hypertension, start metoprolol tartrate at 100 mg once daily and titrate to 200 mg daily as tolerated; however, metoprolol is not recommended for anxiety disorders due to lack of evidence of effectiveness. 1, 2

---

Hypertension Management

Starting Dose and Formulation

• Initiate metoprolol tartrate at 100 mg once daily for most patients with hypertension 3, 4, 5
• In elderly patients (≥65 years) or those with hepatic impairment, start at lower doses (25–50 mg) with cautious gradual titration due to increased drug levels and decreased clearance 6, 3
• The 100 mg once-daily regimen is better tolerated than higher doses in elderly patients 5

Titration Schedule

• Assess response every 2–4 weeks and adjust dosing accordingly 7, 1
• If blood pressure remains uncontrolled after 4 weeks on 100 mg daily, add hydrochlorothiazide 12.5–25 mg rather than increasing metoprolol beyond 200 mg daily 3, 4
• Target maintenance dose is 100–200 mg daily (either once daily or divided into twice-daily dosing) 8, 3, 9
• Doses above 200 mg/day show a relatively flat dose-response curve with minimal additional benefit 9

Alternative Dosing for Specific Situations

Post-Myocardial Infarction:

• Start with metoprolol tartrate 25–50 mg every 6–12 hours orally, then transition over 2–3 days to twice-daily dosing 8, 10
• If IV metoprolol was given (5 mg every 5 minutes up to 15 mg total), begin oral therapy 15 minutes after the last IV dose 8, 6
• Maintenance dose is 100 mg twice daily 8

Heart Failure with Reduced Ejection Fraction:

• Use metoprolol succinate extended-release (not tartrate) starting at 12.5–25 mg once daily 11, 12
• Titrate every 2 weeks to a target of 200 mg once daily 13, 11, 12
• This formulation has proven mortality benefit (34% relative reduction) 11, 12

Monitoring Parameters

Before Initiation:

• Ensure systolic blood pressure ≥90 mm Hg and heart rate ≥50 bpm 8, 14
• Rule out decompensated heart failure, cardiogenic shock, or high-grade AV block 8, 13
• Check for active asthma or severe reactive airway disease (absolute contraindication) 8, 13, 12

During Titration:

• Monitor heart rate and blood pressure at each visit (every 2–4 weeks) 7, 1, 10
• Target heart rate: 50–60 bpm unless limited by adverse effects 12
• Check for signs of worsening heart failure, symptomatic hypotension, or excessive bradycardia (<50 bpm) 13, 10
• In patients with conduction abnormalities (PR interval >0.24 seconds), perform continuous ECG monitoring 8, 12

Metabolic Monitoring:

• When combined with thiazide diuretics, monitor potassium and uric acid levels to detect hypokalemia and hyperuricemia 4

Side-Effect Thresholds and Management

Hold or reduce dose if:

• Systolic blood pressure drops below 90 mm Hg 8, 14
• Heart rate falls below 50 bpm 8, 13, 12
• Signs of heart failure develop (dyspnea, edema, pulmonary congestion) 8, 13
• Symptomatic hypotension occurs (dizziness, lightheadedness) 13

Contraindications:

• Second- or third-degree AV block without a pacemaker 8, 13, 12
• Cardiogenic shock or severe low-output state 8, 12
• Active asthma or severe reactive airway disease 8, 13, 12
• Decompensated heart failure 13, 12

Common Pitfalls:

• Do not abruptly discontinue metoprolol, as this can precipitate rebound hypertension or acute coronary events 12
• Metoprolol tartrate (immediate-release) and metoprolol succinate (extended-release) are not interchangeable without adjusting dosing frequency 11
• In hepatic impairment, metoprolol levels increase substantially; initiate at low doses with cautious titration 6

---

Anxiety Management

Evidence for Metoprolol in Anxiety

Metoprolol is not recommended for anxiety disorders due to insufficient evidence of effectiveness 2

• A 2025 systematic review and meta-analysis found no evidence of beneficial effect of beta-blockers (including propranolol, the most studied agent) compared with placebo or benzodiazepines in patients with social phobia or panic disorder 2
• Despite increasing prescriptions for anxiety (substantial rise between 2003–2018), there is no clinical guidance supporting beta-blocker use for this indication 2
• The included studies had small sample sizes, high risk of bias, and missing data 2

Clinical Context

• While beta-blockers may reduce somatic symptoms of anxiety (tremor, palpitations, sweating) in performance anxiety or situational stress, this is distinct from treating anxiety disorders 2
• If a beta-blocker is considered for situational anxiety despite lack of evidence, propranolol (not metoprolol) is the traditional choice due to its non-selective beta-blockade and CNS penetration, though even propranolol lacks robust evidence 2
• Metoprolol's β₁-selectivity makes it less likely to affect peripheral manifestations of anxiety compared to non-selective agents 12

---

Practical Algorithm

For Hypertension:

1. Start metoprolol tartrate 100 mg once daily (or 25–50 mg in elderly/hepatic impairment) 3, 4, 5
2. Reassess at 4 weeks: Check BP, HR, and tolerability 7, 3
3. If BP uncontrolled: Add hydrochlorothiazide 12.5–25 mg rather than increasing metoprolol 3, 4
4. If BP controlled: Continue current dose and monitor every 2–4 weeks until stable 7, 1
5. Maximum effective dose: 200 mg daily (higher doses offer minimal additional benefit) 5, 9

For Anxiety:

• Do not use metoprolol for anxiety disorders due to lack of evidence 2
• Consider evidence-based treatments: SSRIs, SNRIs, or cognitive-behavioral therapy 2